The DOI matches its Crossref record; 108 of the 113 references it cites were found in a registry or an index; 68 of the 122 sources its claims cite were checked for support.
The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features
Open accessAbstract
Critical review examining the necessity of separating CTE neuropathology from clinical features, noting that CTE might not be pathologically or clinically progressive in a substantial percentage of people.
Overview
CoChat Summary
TL;DR
The paper argues that CTE neuropathology should be separated from the broad clinical features attributed to it, because current evidence does not establish that CTE is inexorably progressive or that its pathology predicts specific symptoms. It calls for more research to determine whether the neuropathology ascribed to neurotrauma is static, progressive, or both.
Key findings
- The 2015 NIH consensus panel defined a single “pathognomonic” CTE criterion—abnormal p-tau in neurons, astrocytes, and cell processes around small vessels in an irregular pattern at the depths of cortical sulci—and listed supportive criteria including superficial-layer pretangles/NFTs, CA2/CA4 hippocampal involvement, subcortical p-tau aggregates, thorny astrocytes at the glial limitans, and grain-like/dot-like structures.
- Postmortem studies report CTE-like pathology in people with other conditions or without known sport exposure: Ling et al. screened 268 cases and found pathology consistent with CTE in 32 (11.9%), all Stage I or II, with mean age at death 81.0 years; Koga et al. found CTE pathology in 8 of 139 multiple system atrophy cases (6%); Noy et al. found Stage I/II CTE pathology in 4.5% of 111 routine neuropathology brains, plus an additional 34 cases (30.6%) with less than Stage I pathology, totaling 35.1%.
- In Bieniek et al., 21 of 66 former athletes (31.8%) had tau pathology suggestive of CTE, all with a separate neurodegenerative disease; 14 of 21 (66.7%) had Stage I or II pathology, and there were no differences between former athletes with versus without CTE pathology in disease onset, disease duration, or age at death.
- Historical evidence from Roberts’ study of boxers—250 selected, 224 examined—found 17% with the syndrome (11% mild, 6% severe); most had a static course, with anecdotal improvement after retirement and only a small subgroup appearing progressive beyond aging.
Methods
- Critical review, not a primary study; it places recent CTE research in historical context and synthesizes neuropathology consensus criteria, postmortem series, and proposed clinical criteria.
- Describes the NIH consensus panel: seven neuropathologists blindly examined 10 advanced CTE cases (2 Stage III, 8 Stage IV; former professional athletes ages 60–85) and 15 cases with primary tau-related neurodegenerative diseases.
- Reviews selected postmortem and clinical studies (e.g., Roberts, Ling, Bieniek, Koga, Noy) and historical literature; no new data collection or meta-analysis is described.
Limitations
- Stated: the consensus panel acknowledged the limitation of using only “moderate to late stage” CTE to develop criteria; there are no prospective, longitudinal, or epidemiological studies supporting the theory that CTE pathology is progressive; there are no agreed upon or validated clinical criteria; and it is unknown whether symptoms can be predicted by specific combinations of neuropathologies, thresholds for accumulation, or regional distributions.
- Stated: a correlation between CTE pathology and depression has not been established, and several reviews focused specifically on suicide concluded there is minimal or no scientific evidence to support suicide as a clinical feature of CTE.
- Evident from the text: as a critical review, its conclusions depend on existing literature and postmortem series, many of which predate the 2015 consensus criteria; the authors note that some past cases may have misclassified PART or ARTAG pathology as CTE, so prevalence estimates might differ under current criteria.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
46 Valid · 7 Not valid · 14 Not checked · 31 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“P-tau in these regions has recently been described in the postmortem brains of patients who had ALS [31], temporal lobe epilepsy [32], and multiple system atrophy [33] but no known history of participation in contact sports or neurotrauma.”
§ The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features1 > CTE-LIKE NEUROPATHOLOGY IN AGING AND OTHER DISEASES
What the sources say
- Partly supportedcites [31] Fournier, 2015, Head injury does not alter disease progression or neuropathologic outcomes in ALS, Neurology sourceExperimental — accuracy not yet measured
In “Head injury and neuropathologic outcomes in ALS” (page not available), the paper reports tau proteinopathy in ALS autopsy cases, including nine without a history of significant head injury. It describes prominent staining deep in cortical sulci, but does not establish the claimed perivascular, subpial, and periventricular distribution or that those patients had no known neurotrauma or contact-sport history. The other diseases have separate citations and are not assessed here. (LLM, conf=0.87)
- Partly supportedcites [32] Puvenna, 2016, Is phosphorylated tau unique to chronic traumatic encephalopathy? Phosphorylated tau in epileptic brain and chronic traumatic encephalopathy, Brain Res sourceExperimental — accuracy not yet measured
The Results and Discussion report perivascular and subpial phosphorylated tau in epileptic brain, and Methods (Epilepsy subjects) says the patients had no known history of traumatic brain injury. However, the epilepsy specimens were surgically resected, not postmortem, and the cited passages do not establish periventricular staining. ALS and multiple system atrophy are attached to other citations in the citing sentence. (LLM, conf=0.88)
- Disputedcites [33] Koga, 2016, Chronic traumatic encephalopathy pathology in multiple system atrophy, J Neuropathol Exp Neurol sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 0 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Perivascular, subpial, and periventricular p-tau immunoreactive NFTs and astrocytic tangles in the neocortex have been reported to be characteristic of both primary age-related tauopathy (PART) [35] and age-related tau astrogliopathy (ARTAG) [36].”
§ The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features1 > CTE-LIKE NEUROPATHOLOGY IN AGING AND OTHER DISEASES
What the sources say
- Disputedcites [35] Crary, 2014, Primary age-related tauopathy (PART): A common pathology associated with human aging, Acta Neuropathol sourceExperimental — accuracy not yet measured
The citation to this paper is attached to the PART portion of the sentence, not the ARTAG portion. In “Neuropathologic changes” (page unavailable), the paper places PART tangles chiefly in the medial temporal lobe and says tau-immunoreactive inclusions are most prominent in neurons. “Future studies and unanswered questions” (page unavailable) distinguishes age-related glial tau pathology from PART and describes PART as predominantly neuronal, contrary to characterizing neocortical astrocytic tangles as a feature of PART. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [36] Kovacs, 2016, Aging-related tau astrogliopathy (ARTAG): Harmonized evaluation strategy, Acta Neuropathol sourceExperimental — accuracy not yet measured
The Evaluation of ARTAG section (page unavailable) identifies subpial, subependymal and perivascular tau-immunoreactive astrocytes, including examples in cortical regions. But the Introduction distinguishes ARTAG’s astrocytic pathology from neuronal neurofibrillary degeneration, and the paper does not characterize perivascular, subpial and periventricular NFTs in the neocortex as ARTAG lesions. Its subependymal example is at the lateral ventricle, not in the neocortex. (LLM, conf=0.88)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In the general population, depression is associated with a wide range of health, mental health, and neurological conditions, such as 1) chronic pain [71–75]; 2) headaches and migraines [76–79]; 3) diabetes [80–82]; 4) low testosterone [83–85]; 5) cardiovascular, cerebrovascular, and small vessel ischemic disease [86–92]; 6) PD [93]; 7) MCI [94–96]; and 8) AD [97].”
§ The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features1 > ARE THE CLINICAL FEATURES KNOWN?
What the sources say
- Not checked — no full text of the sourcecites [71] Atkinson, 1991, Prevalence, onset, and risk of psychiatric disorders in men with chronic low back pain: A controlled study, Pain source
- Not checked — no full text of the sourcecites [72] Fishbain, 1997, Chronic pain-associated depression: Antecedent or consequence of chronic pain? A review, Clin J Pain source
- Not checked — no full text of the sourcecites [73] Wilson, 2002, Major depression and insomnia in chronic pain, Clin J Pain source
- Not checked — no full text of the sourcecites [74] Campbell, 2003, Persistent pain and depression: A biopsychosocial perspective, Biol Psychiatry source
- Not checked — no full text of the sourcecites [75] McWilliams, 2003, Mood and anxiety disorders associated with chronic pain: An examination in a nationally reresentative sample, Pain source
- Not checked — no full text of the sourcecites [76] Hung, 2006, Comorbid migraine is associated with a negative impact on quality of life in patients with major depression, Cephalalgia source
- Not checked — no full text of the sourcecites [77] Breslau, 2000, Headache and major depression: Is the association specific to migraine?, Neurology source
- Not checked — no full text of the sourcecites [78] Breslau, 2003, Comorbidity of migraine and depression: Investigating potential etiology and prognosis, Neurology source
- Not checked — no full text of the sourcecites [79] Sheftell, 2002, Migraine and psychiatric comorbidity: From theory and hypotheses to clinical application, Headache source
- Supportedcites [80] Anderson, 2001, The prevalence of comorbid depression in adults with diabetes: A meta-analysis, Diabetes Care source
This source is cited for the diabetes portion of the sentence, not the other listed conditions. The 'Prevalence of depression in diabetes' section explicitly states that depression is associated with diabetes and reports higher odds of depression among people with diabetes in community studies. The supplied passages do not give a page number. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Nearly all (95%; 20/21) of those with CTE pathology had primary neuropathological diagnoses of a neurodegenerative disease such as AD, frontotemporal dementia, Lewy body disease, or ALS.”
§ The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features1 > CTE-LIKE NEUROPATHOLOGY IN AGING AND OTHER DISEASES
What the sources say
- Supportedcites [38] Bieniek, 2015, Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank, Acta Neuropathol source
The Results report that 20 of the 21 patients with CTE pathology had previously defined neurodegenerative conditions, including AD, Lewy body disease, ALS, and frontotemporal lobar degeneration. Twenty of 21 is approximately 95%. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The consensus report did not indicate that p-tau increases quantitatively on a whole brain level, greater than what would be expected from aging, pre-clinical neurodegeneration, or comorbid neurodegenerative disease.”
§ The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features1 > NEUROPATHOLOGY
What the sources say
- Supportedcites [30] McKee, 2016, The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy, Acta Neuropathol source
The Results (Diagnostic neuropathological features of CTE; page unavailable) define CTE by the location and irregular spatial pattern of p-tau lesions, not by a quantitative whole-brain increase. The Discussion distinguishes those lesions from age-related p-tau pathology, but does not report a whole-brain comparison with aging, preclinical neurodegeneration, or comorbid disease. This supports the claim about what the consensus report did not indicate; it does not establish whether such an increase exists. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
45 more claims · 15 with their cited sources checked
Create a free account to see all 98 claims and to verify the 2 references still open.
- It may state two separate claims as one. 33
- Probably not a substantial claim. 21
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, CTE is described clinically by a set of non-specific but yet severe symptoms including depression, anxiety, motor dysfunction, aggression, irritability, memory loss, and suicidality [4, 68, 94].”
From DNA repair deficiency and senescence in concussed professional athletes involved in contact sports (2019) · cites this paper as [68]
Experimental — accuracy not yet measured
Citations
Cites
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155 · cited 3×
“Because there is evidence that the pathophysiology of AD likely begins many years before the emergence of clinical symptoms or a syndrome such as MCI or dementia, and because the correlation between hallmark lesions and the presence and severity of disease is modest, some in the research community have determined that…”
BackgroundThe Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926
Genetic Epidemiology of Major Depression: Review and Meta-Analysis
Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1552 · Cited by 3,431
Causal Relationship Between Stressful Life Events and the Onset of Major Depression
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.837 · Cited by 2,566
Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury
McKee, A. C., Cantu, R. C., Nowinski, C. J., Hedley-Whyte, E. T., Gavett, B. E., Budson, A. E., Santini, V. E., Lee, H.-S., Kubilus, C. A., & Stern, R. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a9d503 · Cited by 2,295 · cited 3×
“Microscopic features described as characteristic have included 1) localized neuronal and glial accumulations of phosphorylated tau (p-tau) with varying microscopic morphologies, involving perivascular areas of the cerebral cortex and sulcal depths, and with a preference for neurons within superficial cortical laminae;…”
BackgroundThe spectrum of disease in chronic traumatic encephalopathy
McKee, A. C., Stein, T. D., Nowinski, C. J., Stern, R. A., Daneshvar, D. H., Alvarez, V. E., Lee, H.-S., Hall, G., Wojtowicz, S. M., Baugh, C. M., et al. (2013) · Brain · doi:10.1093/brain/aws307 · Cited by 2,098 · cited 10×
“All cases were considered Stage I or Stage II based on the staging system of McKee and colleagues [16], and their mean age of death was 81.”
BackgroundMethodInfluentialThe link between childhood trauma and depression: insights from HPA axis studies in humans
Heim, C., Newport, D. J., Mletzko, T., Miller, A. H., & Nemeroff, C. B. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.03.008 · Cited by 1,704
Primary age-related tauopathy (PART): a common pathology associated with human aging
Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1349-0 · Cited by 1,467 · cited 8×
“PART refers to neuronal tau pathology and ARTAG is characterized by astrocytic tau pathology, although they are not mutually exclusive, and appear to be more a manifestation of age than a subtype of neurodegenerative disease.”
InfluentialNeuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336
Petersen, R. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp0910237 · Cited by 1,289 · cited 1×
“Indeed, the conversion from MCI to AD is difficult to predict, and some patients with MCI improve [108].”
Background
Research works printed but not linked: 4
- Roberts, 1969, Brain damage in boxers: A study of prevalence of traumatic encephalopathy among ex-professional boxers
- Millspaugh, 1937, Dementia pugilistica, U S Nav Med Bull, 35, 297
- Critchley, 1949, Punch-drunk syndromes: The chronic traumatic encephalopathy of boxers. Hommage a Clovis Vincent (ed)
- Vanharanta, 1989, [Back pain], Duodecim, 105, 105
Cited by
American Medical Society for Sports Medicine position statement on concussion in sport
Harmon, K. G., Clugston, J. R., Dec, K., Hainline, B., Herring, S., Kane, S. F., Kontos, A. P., Leddy, J. J., McCrea, M., Poddar, S. K., et al. (2019) · British Journal of Sports Medicine · doi:10.1136/bjsports-2018-100338 · Cited by 482
Graham, N. S., & Sharp, D. J. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317557 · Cited by 340
American Medical Society for Sports Medicine Position Statement on Concussion in Sport
Harmon, K. G., Clugston, J. R., Dec, K., Hainline, B., Herring, S. A., Kane, S., Kontos, A. P., Leddy, J. J., McCrea, M. A., Poddar, S. K., et al. (2019) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0000000000000720 · Cited by 173
“A cause and effect relationship between postmortem CTE changes and antemortem behavioral and cognitive manifestations has not been demonstrated, and, asymptomatic players have had confirmed CTE pathology at autopsy.(105,106) It is also unknown whether CTE is a progressive disease and whether tau deposition is the caus…”
Bieniek, K. F., Blessing, M. M., Heckman, M. G., Diehl, N. N., Serie, A. M., Paolini, M. A., Boeve, B. F., Savica, R., Reichard, R. R., & Dickson, D. W. (2019) · Brain Pathology · doi:10.1111/bpa.12757 · Cited by 131
“9%) Years of education 14 (2, 21) 13 (8, 21) 13 (2, 21) 14 (6, 21) Military 98 (32.”
BackgroundIverson, G. L., Gardner, A. J., Shultz, S. R., Solomon, G. S., McCrory, P. R., ZAFONTE, R. D., Perry, G. L., Hazrati, L., Keene, C. D., & Castellani, R. J. (2019) · Brain · doi:10.1093/brain/awz286 · Cited by 111
Self-citation
Metadata
- Authors
- Iverson, G. L., Keene, C. D., Perry, G., & Castellani, R. J.
- Affiliations
- Harvard University (US)
- University of Washington (US)
- The University of Texas at San Antonio (US)
- Western Michigan University (US)
- Corresponding author
- Iverson, Grant L.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2017-11-28
- Volume
- 61
- Issue
- 1
- Pages
- 17-28
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC5734127
- OpenAlex
- W2765730264
- Cited by
- 72
- References
- 113
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 6 · 2023: 5 · 2022: 4 · 2021: 8 · 2020: 8 · 2019: 19 · 2018: 4
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (submittedVersion, cc-by-nc)
- PubMed Central (submittedVersion, cc-by-nc)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
- Keywords
- chronic traumatic encephalopathy, neuropathology
- MeSH terms
- Neuropathology, Chronic Traumatic Encephalopathy, Cognition Disorders, Humans, Tremor, Disease Progression, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features. https://app.cochat.ai/papers/10.3233/jad-170654
- The paper
- Iverson, G. L., Keene, C. D., Perry, G., & Castellani, R. J. (2017). The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-170654
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.